Nurse Practitioner · Houston, TX
NPI
1023108933
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
267 services
Medicare patients, 2024
209
Average age 73
Drug cost, 2024
$8.5M
1,371 prescriptions
Company payments, 2025
$422
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alice Lynn was code 99214 (office e&m - established), 145 times for 116 patients. In total Alice Lynn billed 267 services in 9 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 145 | 116 | $63.35 | $9,185 |
| 38222 Other Organ Systems | Facility | 55 | 54 | $46.06 | $2,534 |
| 99213 Office E&M - Established | Facility | 33 | 31 | $43.29 | $1,429 |
| 99441 Telephone Services | Facility | 22 | 18 | $23.09 | $508 |
By year: 2022 $21K for 388 services; 2023 $11K for 228 services; 2024 $14K for 267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alice Lynn prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 212 prescriptions and refills. In total Alice Lynn wrote 1,371 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 212 | 595 | 79 | $12K |
| Calquence Acalabrutinib Maleate | 162 | 162 | 19 | $2.0M |
| Imbruvica Ibrutinib | 123 | 123 | 18 | $1.0M |
| Jakafi Ruxolitinib Phosphate | 118 | 118 | 14 | $2.1M |
| Venclexta Venetoclax | 92 | 96 | 18 | $1.1M |
| Pegasys Peginterferon Alfa-2a | 68 | 74 | Under 11 | $166K |
| Allopurinol Generic | 63 | 172 | 32 | $543 |
| Hydroxyurea Generic | 61 | 106 | 21 | $1,317 |
| Jaypirca Pirtobrutinib | 34 | 34 | Under 11 | $736K |
| Pantoprazole Sodium Generic | 27 | 47 | Under 11 | $426 |
| Brukinsa Zanubrutinib | 22 | 22 | Under 11 | $255K |
| Acyclovir Generic | 20 | 40 | Under 11 | $301 |
| Sprycel Dasatinib | 18 | 18 | Under 11 | $98K |
| Zolpidem Tartrate Generic | 17 | 25 | Under 11 | $208 |
| Levofloxacin Generic | 17 | 19 | 12 | $97.81 |
Brand drugs: 731 claims; generic drugs: 640 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alice Lynn $422 ($422 in general payments such as food, travel and fees) from 7 companies. The largest payer was Sobi, Inc with $116.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.